With advances in separation technology and structure elucidation, the main bottleneck limiting drug development from natural products is the identification of their cellular targets. Although effective therapeutic agents can be developed and successfully administered without knowledge of the underlying mechanism of action, elucidation of drug target proteins is essential in the design of new compounds with improved safety and efficacy [1] . However, identification of drug targets remains a difficult and challenging task. Traditional biochemical approaches for target identification rely mainly on in vitro binding assays that are both time consuming and labour intensive. Approaches that combine new combinatorial techniques from molecular biology using libraries of proteins or peptides with chemical approaches are modern alternatives to these traditional technologies in the initial stages of the target discovery process because they can be applied on a genome or proteome wide scale [2] . We are pioneering a technique (reverse chemical proteomics [2] ) that promises to be a rapid discovery technique for cognate drug-receptor pairs resulting in the discovery of new drug targets. In reverse chemical proteomics [3] the bioactive natural product is directly linked to its cellular target protein and the gene for that protein. To achieve this, we firstly biotinylated the natural product and then expose it to an entire proteome expressed on the surface of T7 bacteriophage [4] [5] . Multiple rounds of biopanning allow amplification of the most avid binding partner that can be identified at the gene level. This approach is a modern alternative to traditional technologies in the early target discovery process. In this presentation, we will outline the basic concepts of "reverse chemical proteomics" and show how it can be applied to the rapid discovery of natural product receptors (protein targets) with several examples.
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